Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease

NCT07553377 is registered in ClinicalTrials.gov with Yale University as lead sponsor.

NCT NCT07553377
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07553377 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Digital Pill System to Measure and Support Acamprosate Adherence in Individuals With Alcohol Associated Liver Disease
Lead sponsor
Yale University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
October 31, 2027
Completion date
October 31, 2030
Enrollment
50 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

alcohol associated liver disease, alcohol use disorder, behavioral medicine, medication adherence, medications for alcohol use disorder